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Abstract
Background:  The concurrent management of allergic rhinitis and asthma (ARA) has been
recommended by Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. However, a tool
capable of assessing simultaneously the control of upper and lower airways diseases is lacking.
Aim:  To describe the studies conducted to design the control of ARA test (CARAT)
questionnaire.
Methods: We performed a literature review to generate a list of potentially important items for
the assessment of control of ARA. A formal consensus development process, that used an
innovative web-based application, was designed – 111 experts in ARA and 60 patients participated.
At the final consensus meeting, 25 primary and secondary care physicians formulated the questions
and response options. A qualitative feasibility study (n = 31 patients) was conducted to evaluate the
comprehensibility of the questionnaire while testing two different designs.
Results: Thirty-four potentially important items were identified. All the steps of the consensus
process were completed in 2.5 months. The opinions of experts and patients lead to the
formulation of 17 questions. At the feasibility study the instructions and wording problems were
corrected and a semi-tabular format was chosen.
Conclusion: A tool to measure the control of allergic rhinitis and asthma was developed using a
comprehensive set of methodological steps ensuring the design quality and the face and content
validity. Additional validation studies to assess the psychometric properties of the questionnaire
have started.
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Introduction
Allergic rhinitis and asthma (ARA) are inflammatory dis-
eases and are often associated. The lack of control of these
diseases is responsible for a significant loss in patient's
quality of life and an important socioeconomic burden
[1,2]. According to international guidelines, achievement
of disease control is the primary goal for the treatment of
allergic respiratory diseases [1,3]. Allergic Rhinitis and its
Impact on Asthma (ARIA) [1] guidelines have recently
emphasized in the importance of a combined approach
for both evaluation and management of ARA. Thus, meas-
urement of disease control should consider, concurrently,
the pathologies of upper and lower airways [4].
Based on the definition of asthma control of the Global
Initiative for Asthma [3], chronic disease control can be
characterized as patients experiencing minimal symp-
toms, having no limitations in their activities, having
minimal requirement for rescue medications, having near
normal physiological function, and experiencing infre-
quent exacerbations.
In addition to quality of life questionnaires, symptoms
and severity scores [5-9], several questionnaires for assess-
ing control have been developed for asthma in the last 10
years [10-13]. To a lesser extent the same has happened
for allergic rhinitis [14-16] and control questionnaires are
being validated [1]. However, no questionnaire for meas-
uring the control of ARA concurrently has been devel-
oped. In fact, only Rhinasthma [15] assesses ARA
concurrently, but it is designed for evaluation of health-
related quality of life impairment.
The "Control of Allergic Rhinitis and Asthma Test"
(CARAT) project [17] aims to develop a brief self-admin-
istered tool to quantify the degree of control of ARA in
adult patients with a previous medical diagnosis of ARA.
A fundamental phase for the accuracy and usefulness of
such a tool is its early development. A recent systematic
review recommended that these early steps should
include different methods to ensure the quality of the
questionnaire's design [18].
In this article, we aimed to describe the studies conducted
to design the Control of Allergic Rhinitis and Asthma Test
questionnaire, namely an item generation process, a for-
mal web-supported consensus process and a qualitative
feasibility study.
Questionnaire development
Conceptually, this tool was developed as a self-adminis-
tered questionnaire to quantify the degree of control in
adult patients with a previous diagnosis of ARA, to be
applicable both in clinical practice and research settings.
Therefore, it should be short and easy to complete [19],
while being suitable to assess both individual variations
and discriminate between groups of patients with differ-
ent levels of control.
The questionnaire development comprised 3 fundamen-
tal steps: I) an item generation process, II) a formal con-
sensus process and III) a feasibility study. These steps are
described and discussed independently below.
Item generation process
Methods
We performed a literature search in the Scopus database
(which includes Medline and EMBASE) [20] with the fol-
lowing keywords: 'asthma', 'rhinitis', 'conjunctivitis',
'questionnaire', 'symptom score', 'control' and 'quality of
life' which retrieved a total of 2693 articles. Additional
questionnaires were retrieved from papers' references and
from studies known to the authors. All the questionnaires
were classified according to their purposes and diseases
assessed. All their questions were tabulated. The list with
all the questions was progressively reduced by first elimi-
nating the questions not related to ARA, then the ques-
tions which were repeated or had similar meaning and
finally those not related to control. The remaining ques-
tions were sorted into 10 classes (Lower airways symp-
toms, Nasal symptoms, Ocular symptoms,
Oropharyngeal symptoms, Other symptoms, Activities,
Sleep impairment, Psychosocial impact, Treatment and
Exacerbation). This process allowed us to generate a list of
potentially important items for the assessment of control
of ARA (figure 1).
Results
A total of 29 different questionnaires were identified.
Only 4 questionnaires assessed disease control and were
related to asthma control. The 29 questionnaires com-
prised 425 questions from which 116 were selected (fig-
ure 1). Thirty-four individual potentially important items
were identified from the questions (figure 2) and were
used in the consensus process.
Discussion
The item generation derived from the comprehensive
review of the existing literature, unlike the development
of asthma control questionnaires [11-13].
It led to the creation of a list with all aspects related to the
control of ARA. Moreover, both experts and patients were
asked to suggest additional items in the following rounds.
Formal consensus process
Methods
A formal consensus development process was designed,
informed by the Nominal Group Technique model mod-
ified by the RAND Corporation [21]. It comprised 1) a
public presentation of the project at a national confer-Respiratory Research 2009, 10:52 http://respiratory-research.com/content/10/1/52
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ence, 2) two rounds of experts' contribution via a web
application with feedback after each round, 3) a round of
patients' contribution and 4) a final consensus confer-
ence.
Initial meeting
The project's objectives and outline were presented at the
2007 national annual meeting of the Portuguese Allergology
and Clinical Immunology Society within a session that dis-
cussed the control of ARA. The audience was invited to
answer questions related to the importance of a single ques-
tionnaire assessing simultaneously the control of allergic
rhinitis and asthma, its appropriateness, usefulness and pos-
sible designs, using an on-site televoting system with imme-
diate feedback. The audience responses are presented as
proportions of the respondents for each question; between
28 and 55 delegates answered the different questions.
Experts' contributions
Portuguese experts in ARA were invited to participate in
the consensus process by email. The email addresses (n =
276) were provided by national scientific societies (Portu-
guese Allergology and Clinical Immunology Society and
the Portuguese Pneumology Society) and other organized
groups with interest in ARA.
A total of 111 (40%) experts participated: 81 participated
in the first round and 82 in the second. Fifty-two experts
participated in both rounds.
A web-based application was developed to allow online
interaction with the experts. It gathered theirs input, pro-
vided them feedback at the end of each round, facilitated
the data gathering and analysis, while maintaining ano-
nymity of the answers (for further details see Additional
file 1).
In the first round, each participant was asked to choose 15
items, either from the list of items generated previously or
by suggesting new ones. Then, he/she was asked to rank
those items by importance. Finally, for each of the chosen
items, the participant had to choose between different
characteristics of the items such as intensity or frequency.
For each item, a weighted score was calculated as the
inverse of the proportion of participants who had chosen
it, multiplied by the sum of its rankings. The items were
ranked by this score and plotted in a bar graph.
A shortlist was elaborated with the items with the highest
scores. This shortlist had to include at least two specific
Item generation flowchart Figure 1
Item generation flowchart. From the questions retrieved from published questionnaires, the potentially important items 
were identified. *four were asthma control questionnaires; none were allergic rhinitis control questionnaires; 6 assessed ARA 
concurrently but none its control.Respiratory Research 2009, 10:52 http://respiratory-research.com/content/10/1/52
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items from each class. In addition, the new items sug-
gested by the participants were added to the shortlist.
In the second round, the participants were presented the
shortlist of items generated at the end of the first round,
grouped by classes, and were asked to rank the items
within their classes. For each item we calculated the
inverse of its average ranking, and multiplied it by the
number of items in its class.
In addition, the participants were asked to choose the type
of response options for each item between Visual Analogue
Scales (VAS), different Likert scales or dichotomic scale.
Standard descriptive statistical techniques were used.
Sorted items Figure 2
Sorted items. The 34 items from the item generation phase are presented, ranked by their score (inverse of the proportion 
of participants who chose the item, multiplied by the sum of its rankings). The shortlist (filled bars) included the highest scored 
items and the only item suggested by the participants ("Work/school absenteeism").Respiratory Research 2009, 10:52 http://respiratory-research.com/content/10/1/52
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Patients' contribution
Sixty patients with ARA were enrolled at a hospital-based
allergy outpatient clinic. Patients older than 18 years of
age, with a medical diagnosis of ARA, able to read and fill
the questionnaire and without other respiratory condi-
tions were eligible for participation. Fifty-four were
women, the average (standard deviation) age was 35
(14.4) years. Seventeen (29%) patients had four years of
school education, 20 (35%) had less than twelve and 21
(36%) had twelve or more years of school education; 2
patients didn't provide this information.
The data was collected by a psychologist trained in ques-
tionnaire development. The patients were presented a
paper form with the shortlist of items generated at the end
of the experts' first round, grouped by classes. They were
invited to suggest new items. Then, as in the experts' sec-
ond round, the patients were asked to rank the items
within their classes. For each item we calculated the
inverse of its average ranking, multiplied it by the number
of items in its class and summarized it in a table.
Final meeting
Twenty-five Allergologists, Pneumologists and General
Practitioners, with a special interest in ARA, from different
regions of Portugal, were invited to participate in the final
consensus meeting, independently of having or not par-
ticipated previously in the project.
The session started with an oral presentation of the results
of the previous rounds.
Subsequently, the participants were divided in 3 groups.
Each group was attributed around 12 items belonging to
2 or 3 classes. The group was asked to discuss the results
from the previous rounds and formulate a question and
the response options for each item attributed to them. The
authors provided the participants with examples of ques-
tions from existing questionnaires.
All participants were individually asked to score each item
from 1 to 9 according to its importance (1 being the low-
est). This data was processed on-site, presented to the
panel and used to stimulate the discussion.
Finally, the panel was reassembled and discussed all the
questions, focusing on different aspects related to the
items and their importance, the wording of the questions,
the response options and the timeframe to be assessed. At
the end of the discussion, consensus was reached for all
questions.
The meeting lasted approximately 7 hours.
Results
Initial meeting
At the initial public presentation, four fifths of the audi-
ence (81%) considered that questionnaires assessing the
control of ARA would be useful for the clinical practice.
Moreover, four fifths (81%) preferred a single question-
naire assessing ARA concurrently rather than 2 separate
questionnaires. Nearly half (48%) considered 4 weeks to
be the best time-period to be assessed in the questions.
Nearly half (47%) considered that the questions should
assess the frequency rather than the intensity of the symp-
toms while around one third (38%) considered that the
option between frequency and intensity should be made
for each individual question. More than half (59%) con-
sidered the best scale for the response options to be a Lik-
ert scale (with 4 points (26%), 5 points (20%) or 3 points
(13%)), nearly one third (32%) preferred a VAS, while 9%
preferred a dichotomic (Yes/No) scale.
Experts' and patients' contribution
In the first round each expert chose 15 items and sorted
them by order of importance. Nine out of the 81 partici-
pants (11%) only chose 15 items and didn't sort them by
importance. The score calculated for each item is pre-
sented in figure 2.
After the first round, the shortlist had 22 items, including
the only item suggested by the participants – "Work/
school absenteeism".
Globally, for the 22 items, the participants preferred fre-
quency rather than intensity.
The experts, in their second round, and the patients were
asked to rank the 22 items within their classes. The com-
parison of the ranking by the 2 groups can be seen in table
1. Some differences occurred, mainly in the Nasal symp-
toms class and the Activities class. The greatest difference
occurred with the item "Tiredness".
As for the type of response options, the experts preferred a
Likert scale for 16 items while a dichotomic (Yes/No)
scale was preferred for the remaining 6 items ("Work/
school absenteeism", "Postnasal drip", "Ocular symp-
toms", "Control treatment", "Non-scheduled consulta-
tion" and "Hospitalization"). The VAS wasn't preferred for
any of the items; in fact it was the least chosen option and
its highest proportion of choice was 37%, for the item
"Nasal obstruction".
Final meeting
Within three groups, the physicians discussed and formu-
lated the questions and response options for the items dis-
tributed to each group.Respiratory Research 2009, 10:52 http://respiratory-research.com/content/10/1/52
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The discussion led to the formulation of 17 questions. The
item "Postnasal drip", which had a low ranking, was sub-
stituted by a more general item "Throat complaints, like
pruritus or postnasal drip". The 3 items regarding Ocular
symptoms, generally low ranked, were aggregated in a sin-
gle question. The panel considered the items "Activity lim-
itation", "Daily activities limitation" and "Tiredness"
redundant and rephrased these items. The possibility of
including "Sports activities absenteeism" in the question
referring to the item "Work/school absenteeism" was dis-
cussed. The item "Sleep quality" was considered to have
different interpretations and was replaced by "Symptoms/
complaints after awaking". The items "Control treatment"
and "SOS treatment" were aggregated in one single ques-
tion as "Increase in the use of medication".
The panel decided that 4 weeks should be the timeframe
used for every question. It was considered a period long
enough to have a perspective on control without great dis-
tortion of the patients recollection of events.
When applicable, all the questions referred to frequency
of occurrence, rather than intensity. The response options
for the questions related to Lower airways symptoms,
Nasal symptoms, Ocular symptoms, Sleep impairment
and Activities (apart from "Work/school/sports activities
absenteeism") should be 4-points Likert scales. For each
class the response options were formulated according to
the existing guidelines. For the remaining questions, a
dichotomic (Yes/No) scale was used.
The participants agreed to test, in the following feasibility
study, two versions of the questionnaire, one with a ques-
tion-answer format and another with a tabular format.
The whole formal consensus process was completed in 2.5
months.
Discussion
A formal consensus process was designed to reduce the
number of items, determining which should be included
in the questionnaire. To do so, it was considered necessary
to obtain the opinions of experts in ARA but also to have
a contribution from patients with ARA, unlike other stud-
ies which only include patients in the feasibility or valida-
tion studies [11-13].
The communication with the experts was considerably
simplified by the use of an innovative web-based plat-
form. This platform allowed to contact a large number of
experts in ARA, made the data collection and processing
more efficient while maintaining the safety and anonym-
ity of the information and allowed to provide the partici-
pants with feedback on the rounds' results.
In this way, the contribution of ARA experts and patients
through several steps with different methodological
approaches, allowed the identification of 22 important
items to assess the control of these diseases. The impor-
tance given to the items progressively converged. Discrep-
ancies occurred in a few items, particularly in the
"Activities" and "Nasal symptoms" classes. These discrep-
ancies may result from different interpretations of the
concepts to which the items refer to. For instance, during
the consensus meeting, experts considered "Activities lim-
itation" to be equivalent to what patients considered
"Tiredness". Moreover, the gender imbalance in the
patients sample may have contributed for these differ-
ences.
The final meeting allowed for a thorough discussion of
the items and formulation of the questions and the
response options for the questionnaire by primary and
secondary care physicians.
ARIA proposes VAS to be used in the evaluation of rhinitis
severity [1]. This approach has been successfully tested in
Table 1: Items ranked within classes by the experts (n = 82) at 
the second round and by patients (n = 60).
Experts Patients
Lower airways symptoms
Dyspnoea 2,62 2,22 (1st)
Wheezing 1,80 1,95 (2nd)
Cough 1,35 1,41 (4th)
Chest tightness 1,21 1,46 (3rd)
Nasal symptoms
Nasal obstruction 2,81 1,84 (2nd)
Sneezing 1,80 1,95 (1st)
Rhinorrhoea 1,67 1,55 (4th)
Nasal pruritus 1,58 1,84 (2nd)
Postnasal drip 1,17 1,32 (5>th)
Ocular symptoms
Ocular pruritus 2,02 2,17 (1st)
Ocular symptoms 1,40 1,2 (3rd)
Ocular discharge 1,27 1,42 (2nd)
Activities
Daily activities limitation 2,45 1,80 (2nd)
Activity limitation 1,80 1,47 (3rd)
Work/school absenteeism 1,31 1,13 (4th)
Tiredness 1,30 2,64 (1st)
Sleep impairment
Sleep interruption 1,37 1,41 (1st)
Sleep quality 1,30 1,26 (2nd)
Treatment
Control treatment 1,59 1,67 (1st)
SOS treatment 1,15 1,11 (2nd)
Exacerbation
Non-scheduled consultation 1,41 1,36 (1st)
Hospitalization 1,26 1,30 (2nd)
The items are shown ranked according to the inverse of their average 
ranking by the participants, multiplied by the number of items in the 
class. In bold are the items with highest score and in brackets are 
indicated the order of the ranking by patients. Differences between 
experts and patients are seen in the Nasal symptoms class ("Sneezing" 
and "Nasal obstruction") and the Activities class ("Tiredness").Respiratory Research 2009, 10:52 http://respiratory-research.com/content/10/1/52
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recent studies. However, both at the initial meeting and at
the consensus rounds, the experts preferred either Likert
scales or dichotomic (Yes/No) scales as the response
options for all the items.
Feasibility study
Methods
Thirty-one patients with ARA were enrolled at a hospital-
based allergy outpatient clinic. Patients older than 18
years of age, with a medical diagnosis of ARA, able to read
and fill the questionnaire and without other respiratory
conditions were eligible for participation. Twenty-eight
were women, the average (standard deviation) age was 32
(14.6) years. Six (19%) patients had four years of school
education, 12 (39%) had less than twelve and 13 (42%)
had twelve or more years of school education.
The data was collected by a psychologist trained in ques-
tionnaire development.
The patients were presented two versions of the question-
naire, different in their format. In the first version each
question was followed by its response options (question-
answer format). In the second version, the questions and
response options were presented as tables (tabular for-
mat). Both versions started with a short sentence with the
filling instructions.
All patients completed both versions of the questionnaire,
alternately starting with either the tabular format version
or the question-answer format version. Sixteen patients
completed the tabular format questionnaire first. The time
they took to complete each version was measured. The dif-
ficulties each patient had while completing each version
were registered, as well as their opinions regarding the
wording and comprehensibility of the questions. The pre-
ferred version and the reasons for the choice were also
enquired. The data was processed with standard descrip-
tive statistic techniques.
Results
Overall the patients presented few difficulties completing
either version. Two patients needed assistance to fill the
questionnaire.
Regarding the tabular format, 19 patients didn't report
any difficulties. Seventeen comments were registered, 9 of
them regarding the instructions of the questionnaire and
6 related to the wording of the questions.
As for the question-answer format, 21 patients didn't report
any difficulties filling the questionnaire. Thirteen comments
were registered, 5 of them concerning the wording of the
questions and 5 related to the response options.
Twenty-three patients (74%) preferred the tabular format
and all stated this version was easier and quicker to fill. All
those who preferred the question-answer format consid-
ered it to be easier to understand, with more detailed
information.
The patients took on average (standard deviation) 3' (3.1)
to fill the tabular format version (minimum 1', maximum
12') and 5' (4.9) to fill the question-answer format version
(minimum 2', maximum 20'). The patients took on aver-
age (standard deviation) 1.9' (2.29) less to fill the tabular
version of the questionnaire.
Discussion
The comments of the patients were used to construct a
final version of the questionnaire, correcting important
issues. In the final version, greater emphasis was given to
the instructions of the questionnaire, since the disregard
of these directives was one of the biggest problems found.
The wording of some questions was altered to increase
comprehensibility. The wording of the response options
was changed as it was judged preferable to maintain the
same options throughout the questionnaire.
The test of two different formats of the questionnaire
showed that the tabular format was preferred by most
patients and was quicker to complete. These results
weren't influenced by the order of administration of the 2
versions of the questionnaire (data not shown). However,
26% of the patients considered the question-answer for-
mat to be easier to understand. The chosen layout for the
questionnaire was a semi-tabular format, in order to make
it as clear as possible to the patients.
Conclusion
We describe a formal methodological approach for the
development of a tool to concurrently measure the con-
trol of allergic rhinitis and asthma, in previously diag-
nosed adult patients.
Questionnaires for the assessment of control of either
asthma or rhinitis are in use or under development. How-
ever, a tool capable of assessing simultaneously the con-
trol of upper and lower airways diseases was lacking.
The questionnaire now developed achieves this purpose
(the direct English translation from Portuguese version is
available in submitted Additional file 2). However, it has
17 questions, a considerable number that may hinder its
use in some settings. Additional studies to evaluate the
questionnaire's psychometric properties, reduce the
number of items through analytical processes, establish
the scoring system and assess its usefulness in clinical
practice are being carried out.Respiratory Research 2009, 10:52 http://respiratory-research.com/content/10/1/52
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Moreover, we propose a questionnaire development
approach with a sequence of qualitative methods, includ-
ing an innovative consensus process, supported by web
technologies. It was designed to allow for a large partici-
pation of stakeholders, drawing together the opinions of
experts and patients.
This proposal is in agreement with recently published
quality criteria for questionnaire development [18] and its
different procedures were carried out in order to ensure
the face and content validity and the overall quality of the
instrument's design.
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